These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 2832113

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Accentuated complement activation in patient plasma during the adult respiratory distress syndrome: a potential mechanism for pulmonary inflammation.
    Langlois PF, Gawryl MS, Zeller J, Lint T.
    Heart Lung; 1989 Jan; 18(1):71-84. PubMed ID: 2783581
    [Abstract] [Full Text] [Related]

  • 4. Dissociation of C1 and concentration dependence of its activation kinetics.
    Kilchherr E, Fuchs H, Tschopp J, Engel J.
    Mol Immunol; 1982 May; 19(5):683-91. PubMed ID: 6287243
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Synthesis and regulation of C1 inhibitor in human skin fibroblasts.
    Katz Y, Strunk RC.
    J Immunol; 1989 Mar 15; 142(6):2041-5. PubMed ID: 2537870
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Complement activation and the prognostic value of C3a in patients at risk of adult respiratory distress syndrome.
    Zilow G, Sturm JA, Rother U, Kirschfink M.
    Clin Exp Immunol; 1990 Feb 15; 79(2):151-7. PubMed ID: 2311295
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Preparation and properties of human C1 inhibitor.
    Sim RB, Reboul A.
    Methods Enzymol; 1981 Feb 15; 80 Pt C():43-54. PubMed ID: 6281621
    [No Abstract] [Full Text] [Related]

  • 13. Regulation of the alternative pathway of human complement by C1q.
    Fishelson Z, Müller-Eberhard HJ.
    Mol Immunol; 1987 Sep 15; 24(9):987-93. PubMed ID: 2958692
    [Abstract] [Full Text] [Related]

  • 14. Alternative complement pathway in hypocomplementemic/normal C1s-C1 inhibitor complex patients with SLE.
    Levy RA, Qamar T, Lockshin MD.
    Clin Exp Rheumatol; 1990 Sep 15; 8(1):11-5. PubMed ID: 2347130
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A mechanism for the spontaneous activation of the first component of complement, C1, and its regulation by C1-inhibitor.
    Bianchino AC, Poon PH, Schumaker VN.
    J Immunol; 1988 Dec 01; 141(11):3930-6. PubMed ID: 3183385
    [Abstract] [Full Text] [Related]

  • 17. Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum.
    Mayes JT, Schreiber RD, Cooper NR.
    J Clin Invest; 1984 Jan 01; 73(1):160-70. PubMed ID: 6418767
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The terminal complement complex (sC5b-9) is not specifically associated with the development of the adult respiratory distress syndrome.
    Parsons PE, Giclas PC.
    Am Rev Respir Dis; 1990 Jan 01; 141(1):98-103. PubMed ID: 2297192
    [Abstract] [Full Text] [Related]

  • 20. A rapid and efficient method for the purification of the complement subcomponents C1r and C1s in zymogen form using fast protein chromatography.
    Peitsch MC, Kovacsovics TJ, Isliker H.
    J Immunol Methods; 1988 Apr 06; 108(1-2):265-9. PubMed ID: 2832479
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.